# Recurrent migraine with visual aura as the primary phenotype of familial neuronal intranuclear inclusion disease

**Authors:** Qingxiang Zhang, Min Gao, Yueshan Piao, Sufen Huang, Haitian Nan, Zhen Wang, Junjie Li

PMC · DOI: 10.3389/fneur.2026.1747202 · Frontiers in Neurology · 2026-02-11

## TL;DR

A study identifies migraine with visual aura as a primary symptom in a family with neuronal intranuclear inclusion disease, a rare neurodegenerative disorder.

## Contribution

The study reports a novel presentation of NIID with migraine and visual aura as the main symptom, expanding the known phenotypic spectrum.

## Key findings

- Eight family members presented with migraine and visual aura as the primary symptom of NIID.
- Neuroimaging showed no abnormalities in affected individuals, including no DWI signal changes or leukoencephalopathy.
- Skin biopsies and genetic testing confirmed NIID with NOTCH2NLC GGC repeat expansion in three patients.

## Abstract

Neuronal intranuclear inclusion disease (NIID) is a rare neurodegenerative disorder characterized by highly heterogeneous clinical manifestations and multi-system involvement. The most common initial symptoms include tremor, cognitive impairment, and muscle weakness. Characteristic neuroimaging features comprise symmetrical diffusion-weighted imaging (DWI) high signal intensity in the corticomedullary junction and extensive leukoencephalopathy. NIID manifesting as migraine with visual aura as the predominant symptom has rarely been reported. In this study, we describe a Chinese NIID pedigree comprising eight affected members, all of whom consistently exhibited migraine with visual aura as the primary clinical feature. Notably, none of the followed-up patients showed abnormalities on neuroimaging. In one case, serial follow-up over 7 years revealed no abnormal DWI high signal intensity at the corticomedullary junction or leukoencephalopathy. Skin biopsies confirmed the presence of neuronal intranuclear inclusions in two affected patients within this pedigree. Genetic testing for the NIID-causing mutation identified the GGC repeat expansion in the NOTCH2NLC gene in three patients in this family. This study provides new insights into the phenotypic complexity of NIID.

## Linked entities

- **Genes:** NOTCH2NLC (notch 2 N-terminal like C) [NCBI Gene 100996717]
- **Diseases:** neuronal intranuclear inclusion disease (MONDO:0011327), migraine (MONDO:0005277)

## Full-text entities

- **Genes:** NOTCH2 (notch receptor 2) [NCBI Gene 4853] {aka AGS2, HJCYS, hN2}, NUP62 (nucleoporin 62) [NCBI Gene 23636] {aka IBSN, SNDI, p62}, SCN1A (sodium voltage-gated channel alpha subunit 1) [NCBI Gene 6323] {aka DEE6, DEE6A, DEE6B, DRVT, EIEE6, FEB3}, CACNA1A (calcium voltage-gated channel subunit alpha1 A) [NCBI Gene 773] {aka APCA, BI, CACNL1A4, CAV2.1, DEE42, EA2}, ATP1A2 (ATPase Na+/K+ transporting subunit alpha 2) [NCBI Gene 477] {aka DEE98, FARIMPD, FHM2, MHP2}, NOTCH3 (notch receptor 3) [NCBI Gene 4854] {aka CADASIL, CADASIL1, CARASIL1, CASIL, FPLD1, IMF2}
- **Diseases:** anorexia (MESH:D000855), retinal degeneration (MESH:D012162), edema (MESH:D004487), atrophy (MESH:D001284), cardiorespiratory arrest (MESH:D006323), Dry cough and reduced appetite (MESH:D003371), numbness (MESH:D006987), ocular pain (MESH:D058447), Weight loss (MESH:D015431), lethargy (MESH:D053609), muscle weakness (MESH:D018908), diabetic retinopathy (MESH:D003930), chills (MESH:D023341), lactic acidosis (MESH:D000140), irritability (MESH:D001523), encephalitis (MESH:D004660), macular edema (MESH:D008269), Parkinson's disease (MESH:D010300), tremor (MESH:D014202), sudden unexpected death (MESH:D000080485), photophobia (MESH:D020795), venous occlusion (MESH:D001157), encephalopathy (MESH:D001927), pain (MESH:D010146), altered consciousness (MESH:D003244), clumsiness (MESH:D001259), demyelination (MESH:D003711), blurred vision (MESH:D014786), aura (MESH:D004827), chromatic aberration (MESH:C566125), neurodegenerative disorder (MESH:D019636), mitochondrial encephalomyopathy (MESH:D017237), airway spasms (MESH:D013035), decreased (MESH:D009123), Headache (MESH:D006261), gastrointestinal symptoms (MESH:D012817), visual and memory deterioration (MESH:C531604), vomiting (MESH:D014839), cerebral autosomal dominant arteriopathy (MESH:D020943), autonomic dysfunction (MESH:D001342), memory impairment (MESH:D008569), Cognitive decline (MESH:D003072), blindness (MESH:D001766), movement disorders (MESH:D009069), Migraine (MESH:D008881), fever (MESH:D005334), neurological disorders (MESH:D009461), seizures (MESH:D012640), mutism (MESH:D009155), Mendelian Inheritance in Man (MESH:D030342), MELAS (MESH:D017241), photopsia (MESH:C000726607), NIID (MESH:C537395), dementia (MESH:D003704), acute stroke (MESH:D020521), retinopathy (MESH:D058437), familial hemiplegic migraine (MESH:D020325), cortical abnormalities (MESH:D054220), dysarthria (MESH:D004401), peripheral neuropathy (MESH:D010523)
- **Chemicals:** hematoxylin (MESH:D006416), ibuprofen (MESH:D007052), paraffin (MESH:D010232), formalin (MESH:D005557), topiramate (MESH:D000077236), eosin (MESH:D004801)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** C-39  C

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12932226/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12932226/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12932226/full.md

---
Source: https://tomesphere.com/paper/PMC12932226